Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 2
2017 2
2018 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
Johmura Y, Sun J, Kitagawa K, Nakanishi K, Kuno T, Naiki-Ito A, Sawada Y, Miyamoto T, Okabe A, Aburatani H, Li S, Miyoshi I, Takahashi S, Kitagawa M, Nakanishi M. Johmura Y, et al. Among authors: sawada y. Nat Commun. 2016 Feb 12;7:10574. doi: 10.1038/ncomms10574. Nat Commun. 2016. PMID: 26868148 Free PMC article.
Multiple tophi and exacerbated psoriatic erythroderma.
Mizutani K, Sawada Y, Taniguchi T, Matsushima Y, Kondo M, Akeda T, Nakai Y, Habe K, Yamanaka K. Mizutani K, et al. Among authors: sawada y. J Dermatol. 2020 Jul;47(7):e260-e261. doi: 10.1111/1346-8138.15354. Epub 2020 Apr 30. J Dermatol. 2020. PMID: 32350895 No abstract available.
Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats.
Terawaki K, Kashiwase Y, Uzu M, Nonaka M, Sawada Y, Miyano K, Higami Y, Yanagihara K, Yamamoto M, Uezono Y. Terawaki K, et al. Among authors: sawada y. Oncotarget. 2018 Oct 5;9(78):34748-34764. doi: 10.18632/oncotarget.26190. eCollection 2018 Oct 5. Oncotarget. 2018. PMID: 30410674 Free PMC article.
Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo.
Suzuki M, Chiwaki F, Sawada Y, Ashikawa M, Aoyagi K, Fujita T, Yanagihara K, Komatsu M, Narita M, Suzuki T, Nagase H, Kushima R, Sakamoto H, Fukagawa T, Katai H, Nakagama H, Yoshida T, Uezono Y, Sasaki H. Suzuki M, et al. Among authors: sawada y. PLoS One. 2015 Apr 8;10(4):e0123407. doi: 10.1371/journal.pone.0123407. eCollection 2015. PLoS One. 2015. PMID: 25853862 Free PMC article.
Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
Terawaki K, Kashiwase Y, Sawada Y, Hashimoto H, Yoshimura M, Ohbuchi K, Sudo Y, Suzuki M, Miyano K, Shiraishi S, Higami Y, Yanagihara K, Hattori T, Kase Y, Ueta Y, Uezono Y. Terawaki K, et al. Among authors: sawada y. PLoS One. 2017 Mar 1;12(3):e0173113. doi: 10.1371/journal.pone.0173113. eCollection 2017. PLoS One. 2017. PMID: 28249026 Free PMC article.
New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.
Terawaki K, Sawada Y, Kashiwase Y, Hashimoto H, Yoshimura M, Suzuki M, Miyano K, Sudo Y, Shiraishi S, Higami Y, Yanagihara K, Kase Y, Ueta Y, Uezono Y. Terawaki K, et al. Among authors: sawada y. Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E373-87. doi: 10.1152/ajpendo.00116.2013. Epub 2013 Dec 17. Am J Physiol Endocrinol Metab. 2014. PMID: 24347053 Free article.